SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $28,000 | 0.0% | 406 | +4.6% | 0.01% | 0.0% |
| Q1 2019 | $28,000 | +27.3% | 388 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $22,000 | -31.2% | 388 | -5.6% | 0.01% | -9.1% |
| Q3 2018 | $32,000 | +18.5% | 411 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $27,000 | +58.8% | 411 | +24.9% | 0.01% | +120.0% |
| Q1 2018 | $17,000 | +325.0% | 329 | +376.8% | 0.01% | +400.0% |
| Q4 2017 | $4,000 | +300.0% | 69 | +228.6% | 0.00% | – |
| Q3 2017 | $1,000 | -85.7% | 21 | -84.7% | 0.00% | -100.0% |
| Q2 2017 | $7,000 | +133.3% | 137 | +242.5% | 0.00% | +200.0% |
| Q1 2017 | $3,000 | +200.0% | 40 | +90.5% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |